SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (15033)2/14/1998 1:28:00 AM
From: Flagrante Delictu  Read Replies (2) of 32384
 
Henry, >> ...and retinoids were left in the dust<< Lest some of our threadsters faint at this statement, will you please clarify whether or not you mean that Targretin , a REXINOID, significantly outperformed the retinoid, Tamoxifen &/or other non-LGND retinoids. Also, if you will please post the "Beyond Tamoxifen" paper, you will be accommodating those who have not yet seen it. Thanks again for your dedication, diligence, and data-mining. Bernie.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext